fromFast Company6 months agoMiscellaneousWeightWatchers stock price skyrockets on news that it will offer a compounded GLP-1 weight-loss drug like WegovyWeightWatchers introduces compounded Wegovy to tackle weight-loss industry challenges and capitalize on medication shortages.
fromwww.theguardian.com1 week agoMental healthThe end of WeightWatchers? How the dieting club lost out to slimming drugsWeightWatchers, now WW, may file for bankruptcy due to over $1.4bn debt amid challenges from new weight loss injections.The company faces significant financial difficulties as it adapts to changing market dynamics and consumer preferences.
fromBusiness Insider7 months agoBusinessWeightWatchers' CEO embraced Ozempic. Now she's out of the company.WeightWatchers' CEO Sima Sistani has stepped down amid a transition to focus on weight-loss medications.
fromFast Company6 months agoMedicineBy selling copycat weight-loss drugs, WeightWatchers has become a copycat businessWeightWatchers is pivoting to become an online pharmacy, following the rise of weight-loss medications.The company's stock has increased since the leadership change, reflecting market response to its new direction.
fromFast Company6 months agoMiscellaneousWeightWatchers stock price skyrockets on news that it will offer a compounded GLP-1 weight-loss drug like WegovyWeightWatchers introduces compounded Wegovy to tackle weight-loss industry challenges and capitalize on medication shortages.
fromwww.theguardian.com1 week agoMental healthThe end of WeightWatchers? How the dieting club lost out to slimming drugsWeightWatchers, now WW, may file for bankruptcy due to over $1.4bn debt amid challenges from new weight loss injections.The company faces significant financial difficulties as it adapts to changing market dynamics and consumer preferences.
fromBusiness Insider7 months agoBusinessWeightWatchers' CEO embraced Ozempic. Now she's out of the company.WeightWatchers' CEO Sima Sistani has stepped down amid a transition to focus on weight-loss medications.
fromFast Company6 months agoMedicineBy selling copycat weight-loss drugs, WeightWatchers has become a copycat businessWeightWatchers is pivoting to become an online pharmacy, following the rise of weight-loss medications.The company's stock has increased since the leadership change, reflecting market response to its new direction.
fromFast Company7 months agoBusinessWeightWatchers CEO Sima Sistani is leaving the companySima Sistani's departure marks a pivotal shift for WeightWatchers, reflecting challenges and transformation in the digital health landscape.